FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4376505719> ?p ?o ?g. }

• W4376505719 abstract "Study objectives Ketorolac is a commonly used nonopioid parenteral analgesic for treating emergency department (ED) patients with acute pain. Our systematic review aims to summarize the available evidence by comparing the efficacy and safety of differing ketorolac dosing strategies for acute pain relief in the ED. Methods The review was registered on PROSPERO (CRD42022310062). We searched MEDLINE, PubMed, EMBASE, and unpublished sources from inception through December 9, 2022. We included randomized control trials of patients presenting with acute pain to the ED, comparing ketorolac doses less than 30 mg (low dose) to ketorolac doses more than or equal to 30 mg (high dose) for the outcomes of pain scores after treatment need for rescue analgesia, and incidence of adverse events. We excluded patients in non-ED settings, including postoperative settings. We extracted data independently and in duplicate and pooled them using a random-effects model. We assessed the risk of bias using the Cochrane Risk of Bias 2 tool and the overall certainty of the evidence for each outcome using the Grading Recommendations Assessment, Development, and Evaluation approach. Results This review included 5 randomized controlled trials (n=627 patients). Low-dose parenteral ketorolac (15 to 20 mg), as compared to high-dose ketorolac (≥30 mg), probably has no effect on pain scores (mean difference 0.05 mm lower on 100 mm visual analog scale, 95% confidence interval [CI] -4.91 mm to +5.01 mm; moderate certainty). Further, low-dose ketorolac at 10 mg may have no effect on pain scores compared to high-dose ketorolac (mean difference 1.58 mm lower on 100 mm visual analog scale, 95% CI -8.86 mm to +5.71 mm; low certainty). Low-dose ketorolac may increase the need for rescue analgesia (risk ratio 1.27, 95% CI 0.86 to 1.87; low certainty) and may have no difference on rates of adverse events (risk ratio 0.84, 95% CI 0.54 to 1.33; low certainty). Conclusion In adult ED patients with acute pain, parenteral ketorolac given at doses of 10 mg to 20 mg is probably as effective in relieving pain as doses of 30 mg or higher. Low-dose ketorolac may have no effect on adverse events, but these patients may require more rescue analgesia. This evidence is limited by imprecision and is not generalizable to children or those at higher risk of adverse events. Ketorolac is a commonly used nonopioid parenteral analgesic for treating emergency department (ED) patients with acute pain. Our systematic review aims to summarize the available evidence by comparing the efficacy and safety of differing ketorolac dosing strategies for acute pain relief in the ED. The review was registered on PROSPERO (CRD42022310062). We searched MEDLINE, PubMed, EMBASE, and unpublished sources from inception through December 9, 2022. We included randomized control trials of patients presenting with acute pain to the ED, comparing ketorolac doses less than 30 mg (low dose) to ketorolac doses more than or equal to 30 mg (high dose) for the outcomes of pain scores after treatment need for rescue analgesia, and incidence of adverse events. We excluded patients in non-ED settings, including postoperative settings. We extracted data independently and in duplicate and pooled them using a random-effects model. We assessed the risk of bias using the Cochrane Risk of Bias 2 tool and the overall certainty of the evidence for each outcome using the Grading Recommendations Assessment, Development, and Evaluation approach. This review included 5 randomized controlled trials (n=627 patients). Low-dose parenteral ketorolac (15 to 20 mg), as compared to high-dose ketorolac (≥30 mg), probably has no effect on pain scores (mean difference 0.05 mm lower on 100 mm visual analog scale, 95% confidence interval [CI] -4.91 mm to +5.01 mm; moderate certainty). Further, low-dose ketorolac at 10 mg may have no effect on pain scores compared to high-dose ketorolac (mean difference 1.58 mm lower on 100 mm visual analog scale, 95% CI -8.86 mm to +5.71 mm; low certainty). Low-dose ketorolac may increase the need for rescue analgesia (risk ratio 1.27, 95% CI 0.86 to 1.87; low certainty) and may have no difference on rates of adverse events (risk ratio 0.84, 95% CI 0.54 to 1.33; low certainty). In adult ED patients with acute pain, parenteral ketorolac given at doses of 10 mg to 20 mg is probably as effective in relieving pain as doses of 30 mg or higher. Low-dose ketorolac may have no effect on adverse events, but these patients may require more rescue analgesia. This evidence is limited by imprecision and is not generalizable to children or those at higher risk of adverse events." @default.
• W4376505719 created "2023-05-15" @default.
• W4376505719 creator A5015221914 @default.
• W4376505719 creator A5020199126 @default.
• W4376505719 creator A5024032808 @default.
• W4376505719 creator A5064354115 @default.
• W4376505719 creator A5091941704 @default.
• W4376505719 date "2023-05-01" @default.
• W4376505719 modified "2023-10-09" @default.
• W4376505719 title "Comparative Effectiveness of Ketorolac Dosing Strategies for Emergency Department Patients With Acute Pain" @default.
• W4376505719 cites W1537972189 @default.
• W4376505719 cites W1981680557 @default.
• W4376505719 cites W1993543595 @default.
• W4376505719 cites W1999714065 @default.
• W4376505719 cites W2009326492 @default.
• W4376505719 cites W2015698186 @default.
• W4376505719 cites W2043727245 @default.
• W4376505719 cites W2047173081 @default.
• W4376505719 cites W2052276190 @default.
• W4376505719 cites W2057812714 @default.
• W4376505719 cites W2064740177 @default.
• W4376505719 cites W2068984440 @default.
• W4376505719 cites W2074103719 @default.
• W4376505719 cites W2080236092 @default.
• W4376505719 cites W2087559496 @default.
• W4376505719 cites W2090132603 @default.
• W4376505719 cites W2093043874 @default.
• W4376505719 cites W2107328434 @default.
• W4376505719 cites W2109346853 @default.
• W4376505719 cites W2115911719 @default.
• W4376505719 cites W2125435699 @default.
• W4376505719 cites W2125637902 @default.
• W4376505719 cites W2157823046 @default.
• W4376505719 cites W2165010366 @default.
• W4376505719 cites W2167505959 @default.
• W4376505719 cites W2396931796 @default.
• W4376505719 cites W2563200124 @default.
• W4376505719 cites W2582248000 @default.
• W4376505719 cites W2620944605 @default.
• W4376505719 cites W2800072530 @default.
• W4376505719 cites W2890396463 @default.
• W4376505719 cites W2904363872 @default.
• W4376505719 cites W2969937873 @default.
• W4376505719 cites W2970684805 @default.
• W4376505719 cites W2983079501 @default.
• W4376505719 cites W3024364032 @default.
• W4376505719 cites W3047950129 @default.
• W4376505719 cites W3056082644 @default.
• W4376505719 cites W3114735222 @default.
• W4376505719 cites W3189285621 @default.
• W4376505719 cites W4230531339 @default.
• W4376505719 cites W4239370413 @default.
• W4376505719 cites W4292059951 @default.
• W4376505719 doi "https://doi.org/10.1016/j.annemergmed.2023.04.011" @default.
• W4376505719 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37178102" @default.
• W4376505719 hasPublicationYear "2023" @default.
• W4376505719 type Work @default.
• W4376505719 citedByCount "0" @default.
• W4376505719 crossrefType "journal-article" @default.
• W4376505719 hasAuthorship W4376505719A5015221914 @default.
• W4376505719 hasAuthorship W4376505719A5020199126 @default.
• W4376505719 hasAuthorship W4376505719A5024032808 @default.
• W4376505719 hasAuthorship W4376505719A5064354115 @default.
• W4376505719 hasAuthorship W4376505719A5091941704 @default.
• W4376505719 hasConcept C118552586 @default.
• W4376505719 hasConcept C126322002 @default.
• W4376505719 hasConcept C14184104 @default.
• W4376505719 hasConcept C168563851 @default.
• W4376505719 hasConcept C197934379 @default.
• W4376505719 hasConcept C2777288759 @default.
• W4376505719 hasConcept C2778446825 @default.
• W4376505719 hasConcept C2780724011 @default.
• W4376505719 hasConcept C2780820201 @default.
• W4376505719 hasConcept C2909274023 @default.
• W4376505719 hasConcept C42219234 @default.
• W4376505719 hasConcept C44249647 @default.
• W4376505719 hasConcept C71924100 @default.
• W4376505719 hasConceptScore W4376505719C118552586 @default.
• W4376505719 hasConceptScore W4376505719C126322002 @default.
• W4376505719 hasConceptScore W4376505719C14184104 @default.
• W4376505719 hasConceptScore W4376505719C168563851 @default.
• W4376505719 hasConceptScore W4376505719C197934379 @default.
• W4376505719 hasConceptScore W4376505719C2777288759 @default.
• W4376505719 hasConceptScore W4376505719C2778446825 @default.
• W4376505719 hasConceptScore W4376505719C2780724011 @default.
• W4376505719 hasConceptScore W4376505719C2780820201 @default.
• W4376505719 hasConceptScore W4376505719C2909274023 @default.
• W4376505719 hasConceptScore W4376505719C42219234 @default.
• W4376505719 hasConceptScore W4376505719C44249647 @default.
• W4376505719 hasConceptScore W4376505719C71924100 @default.
• W4376505719 hasLocation W43765057191 @default.
• W4376505719 hasLocation W43765057192 @default.
• W4376505719 hasOpenAccess W4376505719 @default.
• W4376505719 hasPrimaryLocation W43765057191 @default.
• W4376505719 hasRelatedWork W1575078433 @default.
• W4376505719 hasRelatedWork W1646525527 @default.
• W4376505719 hasRelatedWork W1989067833 @default.
• W4376505719 hasRelatedWork W2029470398 @default.
• W4376505719 hasRelatedWork W2054508767 @default.
• W4376505719 hasRelatedWork W2061531122 @default.

• next